Further evidence of the trypanocidal action of eupomatenoid-5: Confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in trypanothione reductase activity  by Lazarin-Bidóia, D. et al.
Free Radical Biology and Medicine 60 (2013) 17–28Contents lists available at SciVerse ScienceDirectFree Radical Biology and Medicine0891-58
http://d
n Corr
E-mjournal homepage: www.elsevier.com/locate/freeradbiomedOriginal contributionFurther evidence of the trypanocidal action of eupomatenoid-5:
Conﬁrmation of involvement of reactive oxygen species and
mitochondria owing to a reduction in trypanothione
reductase activity
D. Lazarin-Bido´ia a, V.C. Desoti a, T. Ueda-Nakamura a,b, B.P. Dias Filho a,b,
C.V. Nakamura a,b, S.O. Silva a,b,n
a Programa de Po´s Graduac- ~ao em Cieˆncias Farmaceˆuticas, Universidade Estadual de Maringa´, 87020-900 Maringa´, PR, Brasil
b Departamento de Cieˆncias Ba´sicas da Sau´de, Universidade Estadual de Maringa´, 87020-900 Maringa´, PR, Brasila r t i c l e i n f o
Article history:
Received 5 November 2012
Accepted 11 January 2013








Free radicals49 & 2013 Elsevier Inc.
x.doi.org/10.1016/j.freeradbiomed.2013.01.00
esponding author. Fax: þ55 44 3011 4860.
ail address: lautenschlager@uem.br (S.O. Silva
Open access under ta b s t r a c t
Our group assays natural products that are less toxic and more effective than available nitroheterocycles
as promising therapeutic options for patients with Chagas disease. Our previous study reported the
trypanocidal activity of eupomatenoid-5, a neolignan isolated from the leaves of Piper regnellii var.
pallescens, against the three main parasitic forms of Trypanosoma cruzi. The present study further
characterizes the biochemical and morphological alterations induced by this compound to elucidate the
mechanisms of action involved in the cell death of T. cruzi. We show that eupomatenoid-5 induced
oxidative imbalance in the three parasitic forms, especially trypomastigotes, reﬂected by a decrease in the
activity of trypanothione reductase and increase in the formation of reactive oxygen species (ROS). A
reduction of mitochondrial membrane potential was then triggered, further impairing the cell redox
system through the production of more ROS and reactive nitrogen species. Altogether, these effects led to
oxidative stress, reﬂected by lipid peroxidation and DNA fragmentation. These alterations are key events in
the induction of parasite death through various pathways, including apoptosis, necrosis, and autophagy.
& 2013 Elsevier Inc. Open access under the Elsevier OA license. Introduction
Chagas disease, caused by the protozoan Trypanosoma cruzi, is
considered a serious public health problem that affects approxi-
mately 10 million people in Latin America. The incidence of this
disease has been estimated to include 300,000 new cases per year,
and approximately 10,000 people die from this infection annually
[1–3]. Since its discovery in 1909 [4], the treatment of this
infection is still challenging because it is restricted to only two
nitroderivative compounds, benznidazole and nifurtimox, that
have limited efﬁcacy, especially in the chronic phase of the
disease, and serious side effects [5].
An urgent need exists for new active compounds that are less
toxic and more effective for the treatment of patients with Chagas
disease. Numerous studies have reported natural compounds
with selective trypanocidal action [6]. Natural products are
promising for the treatment of both infectious and noninfectious
diseases because of the diversity of their molecular structures [6].
However, few studies have reported the efﬁcacy of trypanocidal
compounds against the three forms of T. cruzi [7,8]. The scarcity of8
).
he Elsevier OA license. such studies is reasonable because of the complex life cycle and
distinct morphological and functional forms of T. cruzi [9,10].
Another important issue is that few studies have demonstrated
the likely mechanisms of action of these trypanocidal compounds.
Our group recently reported the trypanocidal activity of
eupomatenoid-5, a neolignan isolated from the leaves of Piper
regnellii var. pallescens, against epimastigote, trypomastigote, and
amastigote forms of T. cruzi [11–13]. This compound induced
ultrastructural alterations and was shown to be more selective for
parasitic cells than for mammalian cells [12,13].
Considering the trypanocidal activity of eupomatenoid-5, this
study sought to better characterize the biochemical alterations
induced by this compound in the three parasitic forms of T. cruzi.
Our goal was to elucidate the mechanisms of action of
eupomatenoid-5 involved in the cell death of T. cruzi. Based on
our previous work [13], we focused our study on mitochondrial
dysfunction and plasma membrane disruption induced by
eupomatenoid-5. Our results provide further insights into the
mechanisms of action of eupomatenoid-5 and strongly suggest
that eupomatenoid-5 effectively treats Chagas disease with
remarkable trypanocidal action against both forms of T. cruzi
(i.e., trypomastigotes and amastigotes) that are relevant for
mammalian infection. We suggest that the primary target for
eupomatenoid-5 may be the trypanothione system, a pathway
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This system is highly dependent on trypanothione reductase (TR)
and plays a key role in the antioxidant activity of trypanosoma-
tids [14].Materials and methods
Chemicals
Actinomycin D, antimycin A (AA), bovine serum albumin,
carbonyl cyanide m-chlorophenylhydrazone (CCCP), digitonin,
dihydrorhodamine 123 (DHR), dimethyl sulfoxide (DMSO), mono-
dansylcadaverine (MDC), rhodamine 123 (Rh123), thiobarbituric
acid, wortmannin, and 5,50-dithiobis(2-nitrobenzoic acid) (DTNB)
were purchased from Sigma–Aldrich (St. Louis, MO, USA). Dul-
becco’s modiﬁed Eagle’s medium (DMEM) and fetal bovine serum
(FBS) were obtained from Invitrogen (Grand Island, NY, USA).
Annexin-V FITC, the 3,8-phenanthridinediamine-5-(6-triphenyl-
phosphoniumhexyl)-5,6-dihydro-6-phenyl (MitoSOX) kit, propi-
dium iodide (PI), and the terminal deoxynucleotide transferase
dUTP nick-end labeling (TUNEL) kit were obtained from Invitro-
gen (Eugene, OR, USA). The protein assay kit was obtained from
Bio-Rad (Hercules, CA, USA). All of the other reagents were of
analytical grade.
Isolation of eupomatenoid-5 from leaves of P. regnellii var. pallescens
Eupomatenoid-5 (Fig. 1) was isolated from the leaves of
P. regnellii collected in the Prof. Irenice Silva Garden of Medicinal
Plants on the campus of the State University of Maringa (UEM) in
Parana, Brasil. A voucher specimen (No. HUM 8392) was depos-
ited at the UEM herbarium. The dry plant material was extracted
by exhaustive maceration at room temperature in the dark in
ethanol:water (90:10). Fractionation was performed from the
ethyl acetate crude extract to obtain the hexane fraction, and a
dihydrobenzofuran neolignan, eupomatenoid-5, was isolated
from this fraction as described previously [11]. The compound
was puriﬁed using absorption–chromatographic methods and
identiﬁed by analyzing the ultraviolet, infrared, 1H nuclear mag-
netic resonance (NMR), 13C NMR, distortionless enhancement
polarization transfer, correlated spectroscopy, heteronuclear cor-
relation, nuclear Overhauser effect spectroscopy, heteronuclear
multiple bond correlation, and gas chromatography/mass spec-
trometry spectra. The data were compared with the literature
[15].
Stock solutions of eupomatenoid-5 were prepared aseptically
in DMSO and diluted in culture medium so that the DMSO
concentration did not exceed 1% in the experiments. TheFig. 1. Structure of eupomatenoid-5, the neolignan isolated from the leaves of
P. regnellii var. pallescens.concentrations of eupomatenoid-5 used in the assays were based
on the IC50 and IC90 values [11].
Parasites and cell cultures
All of the experiments were performed using the Y strain of T.
cruzi. Epimastigote forms were maintained axenically at 28 1C
with weekly transfers in liver infusion tryptose medium supple-
mented with 10% heat-inactivated FBS at pH 7.4 [16]. Trypomas-
tigote and amastigote forms were obtained from the supernatants
of previously infected monolayers of LLCMK2 cells (i.e., epithelial
cells of monkey kidney (Macaca mulatta); CCL-7; American Type
Culture Collection, Rockville, MD, USA) in DMEM supplemented
with 2 mM L-glutamine, 10% FBS, and 50 mg/L gentamicin and
buffered with sodium bicarbonate in a 5% CO2 air mixture at
37 1C.
Mitochondrial membrane potential assay
Mitochondrial membrane potential (DCm) was evaluated
during exposure of epimastigote forms (1107 cells/ml) to 23.8,
51.0, and 170.0 mM eupomatenoid-5 for 3 h at 28 1C and exposure
of trypomastigote and amastigote forms (1107 cells/ml) to 34.0,
68.0, and 170.0 mM eupomatenoid-5 for 3 h at 37 1C using the
ﬂuorescent probe Rh123, which accumulates within mitochon-
dria. Afterward, the parasites were washed and incubated with
5 mg/ml Rh123 for 15 min to verify DCm. CCCP (100.0 mM) was
used as a positive control. The data acquisition and analysis were
performed using a FACSCalibur ﬂow cytometer (Becton–Dickin-
son, Rutherford, NJ, USA) equipped with CellQuest software
(Joseph Trotter, The Scripps Research Institute, La Jolla, CA,
USA). A total of 10,000 events were acquired in the region that
was previously established as the one that corresponded to the
parasites. Alterations in Rh123 ﬂuorescence were quantiﬁed using
an index of variation (IV) obtained from the equation (MTMC)/MC,
in which MT is the median ﬂuorescence for the treated parasites
and MC is the median ﬂuorescence for the control parasites.
Negative IV values correspond to depolarization of the mitochon-
drial membrane.
Cell membrane integrity assay
Cell membrane integrity was evaluated during exposure of
epimastigote forms (1107 cells/ml) to 23.8, 51.0, and 170.0 mM
eupomatenoid-5 for 3 h at 28 1C and exposure of trypomastigote
and amastigote forms (1107 cells/ml) to 34.0, 68.0, and
170.0 mM eupomatenoid-5 for 3 h at 37 1C using PI, a probe that
binds to DNA in ruptured membrane cells. Afterward, the para-
sites were washed and incubated with 0.2 mg/ml PI for 10 min to
verify cell membrane integrity. Digitonin (40.0 mM) was used as a
positive control. Data acquisition and analysis were performed
using a FACSCalibur ﬂow cytometer equipped with CellQuest
software. A total of 10,000 events were acquired in the region
that was previously established as the one that corresponded to
the parasites. Alterations in the ﬂuorescence of PI were quantiﬁed
as the percentage of increase in the ﬂuorescence compared with
the control (untreated parasites).
Fluorimetric detection of mitochondrial-derived superoxide anion
(O2
d)
The mitochondrial production of O2
d was evaluated during
exposure of epimastigote forms to 23.8, 51.0, and 170.0 mM
eupomatenoid-5 and exposure of trypomastigote and amastigote
forms to 34.0, 68.0, and 170.0 mM eupomatenoid-5 using the
ﬂuorescent O2
d-sensitive, mitochondrial-targeted probe MitoSOX.
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10 min at 22 1C and then washed with Krebs–Henseleit (KH) buffer
(pH 7.3) that contained 15 mM NaHCO3, 5 mM KCl, 120 mM NaCl,
0.7 mM Na2HPO4, and 1.5 mM NaH2PO4. Loaded cells were
exposed to the stimuli, and after suitable times ﬂuorescence was
measured in a ﬂuorescence microplate reader (Victor X3; Perki-
nElmer) at lex¼510 nm and lem¼580 nm. Oxidized MitoSOX
becomes highly ﬂuorescent upon binding to nucleic acids. Cells
were exposed to 10 mM AA, a stimulus known to induce mitochon-
drial O2
d production.
Fluorimetric detection of oxidant species production
The production of oxidant species (reactive oxygen and nitro-
gen species (ROS/RNS)) was evaluated during exposure of epi-
mastigote forms to 23.8, 51.0, and 170.0 mM eupomatenoid-5 and
exposure of trypomastigote and amastigote forms to 34.0, 68.0,
and 170.0 mM eupomatenoid-5 using the nonﬂuorescent probe
DHR by measuring its oxidation to the ﬂuorescent product Rh123
[17]. Parasites (2107 cells/ml) were loaded with 50 mM DHR for
30 min at 37 1C and washed with KH buffer (pH 7.3) to eliminate
unincorporated probe. Loaded cells were exposed to the stimuli,
and after suitable times Rh123 ﬂuorescence was determined in a
ﬂuorescence microplate reader (Victor X3; PerkinElmer) at
lex¼485 nm and lem¼520 nm. AA (10 mM) was used as a positive
control.
Estimation of decrease in reduced thiol level
In the trypanothione system, trypanothione is reduced to a
dithiol T(SH)2 by TR. The inhibition of TR decreases total reduced
thiol [18]. Free thiol levels were determined using DTNB. Epimas-
tigote forms were treated with 23.8, 51.0, and 170.0 mM
eupomatenoid-5 for 3, 24, and 96 h at 28 1C. Trypomastigote
and amastigote forms were treated with 34.0, 68.0, and 170.0 mM
eupomatenoid-5 for 3 and 24 h at 37 1C. Afterward, the cells
(1107 cells/ml) were centrifuged, dissolved in 10 mM Tris–HCl
buffer (pH 2.5), and sonicated. Acidic pH was used during
sonication to prevent oxidation of the free thiol groups. Cellular
debris was removed by centrifugation, and 100 ml of the super-
natant and 100 ml of 500 mM phosphate buffer (pH 7.5) were
placed in each microtiter well, followed by the addition of 20 ml of
1 mM DTNB to each well. Absorbance was measured at 412 nm.
Lipid peroxidation assay
The extent of lipid peroxidation was determined as the
amount of thiobarbituric acid-reactive substances (TBARS) in
terms of malondialdehyde (MDA). Epimastigote forms (12 mg/
ml) were treated with 23.8, 51.0, and 170.0 mM eupomatenoid-5
for 3 h at 28 1C. Trypomastigote and amastigote forms (12 mg/ml)
were treated with 34.0, 68.0, and 170.0 mM eupomatenoid-5 for
3 h at 37 1C. After incubation, the samples (0.5 mg protein) were
heated in a solution that contained 0.37% thiobarbituric acid, 15%
trichloroacetic acid, and 0.25 N HCl for 45 min at 95 1C. After
cooling, absorbance was read at 532 nm, and the TBARS concen-
tration was calculated based on an e value of 153,000 M1 cm1
[19].
DNA fragmentation
DNA double-strand ruptures were evaluated in situ using
TUNEL. Epimastigote forms (1107 cells/ml) were treated with
23.8, 51.0, and 170.0 mM eupomatenoid-5 for 24 h at 28 1C.
Trypomastigote and amastigote forms (1107 cells/ml) were
treated with 34.0, 68.0, and 170.0 mM eupomatenoid-5 for 24 hat 37 1C. Afterward, the cells were ﬁxed and subjected to the
TUNEL assay according to the manufacturer’s instructions. Acti-
nomycin D (10.0 mg/ml) was used as a positive control. The nuclei
were counterstained with PI, which denotes the condensation and
margination of chromatin. Cells that undergo DNA double-strand
ruptures should ﬂuoresce brightly when viewed with appropriate
ﬁlter sets, unlike the untreated cells. Fluorescence was observed
under an Olympus BX51 ﬂuorescence microscope, and pictures
were captured using an Olympus UC30 camera.Phosphatidylserine exposure
Phosphatidylserine exposure was detected using annexin-V
FITC, a calcium-dependent phospholipid binding protein. Epimas-
tigote forms (1107 cells/ml) were treated with 23.8, 51.0, and
170.0 mM eupomatenoid-5 for 3 h at 28 1C. Trypomastigote and
amastigote forms (1107 cells/ml) were treated with 34.0, 68.0,
and 170.0 mM eupomatenoid-5 for 3 h at 37 1C. Afterward, the
cells were washed and resuspended in 100 ml of binding buffer
(140 mM NaCl, 5 mM CaCl2, and 10 mM Hepes–Na, pH 7.4),
followed by the addition of 5 ml annexin-V FITC for 15 min at
room temperature. Binding buffer (400 ml) and 50 ml PI were then
added. AA (125.0 mM) was used as a positive control. Data
acquisition and analysis were performed using a FACSCalibur
ﬂow cytometer equipped with CellQuest software. A total of
10,000 events were acquired in the region that was previously
established as the one that corresponded to the parasites. Cells
that were stained with annexin-V (PI positive or negative) were
considered apoptotic, and cells that were only PI positive were
considered necrotic [20].Cell volume determination
Epimastigote forms (1107 cells/ml) treated with 23.8, 51.0,
and 170.0 mM eupomatenoid-5 for 3 h at 28 1C and trypomasti-
gote and amastigote forms (1107 cells/ml) treated with 34.0,
68.0, and 170.0 mM eupomatenoid-5 for 3 h at 37 1C were col-
lected by centrifugation, washed twice in phosphate-buffered
saline (PBS), resuspended in PBS, and analyzed using
ﬂuorescence-activated cell sorting and a FACSCalibur ﬂow cyto-
meter. Actinomycin D (20.0 mM) was used as a positive control. A
total of 10,000 events were acquired in the region that was
previously established as the one that corresponded to the
parasites. Histograms were generated, and the analysis was
performed using CellQuest software; forward light scatter (FSC-
H) represents the cell volume.Evaluation of autophagic vacuoles
Autophagic vacuoles were evaluated using labeling with MDC,
a ﬂuorescent probe that accumulates in autophagic vacuoles
[21,22]. Epimastigote forms (1107 cells/ml) were treated with
23.8, 51.0, and 170.0 mM eupomatenoid-5 for 24 h at 28 1C, and
trypomastigote and amastigote forms (1107 cells/ml) were
treated with 34.0, 68.0, and 170.0 mM eupomatenoid-5 for 24 h
at 37 1C. The cells were then incubated with 0.05 mM MDC in PBS
for 15 min. After incubation, the cells were washed twice in PBS.
MDC stain was analyzed using an Olympus BX51 ﬂuorescence
microscope, and images were captured using a UC30 camera.
In some of the experiments, before the induction of autophagy,
the cells were pretreated with wortmannin, a potent inhibitor of
PI3 kinase, an enzyme associated with the signaling pathway
involved in the regulation of autophagy [23].
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The data shown in the graphs are expressed as the means 7
standard error of the mean of independent preparations. The data
were analyzed using one- and two-way analysis of variance.
Signiﬁcant differences among means were identiﬁed using the
Tukey post hoc test. Values of pr0.05 were considered statisti-
cally signiﬁcant. Statistical analyses were performed using the
Statistica software package.Results
Effect of eupomatenoid-5 on the mitochondrial membrane potential
of T. cruzi
A previous electron microscopy study showed the effect of
eupomatenoid-5 on T. cruzi mitochondria [12]. Based on this, we
decided to evaluate the DCm in eupomatenoid-5-treated para-
sites. The histograms showed a marked decrease in total Rh123
ﬂuorescence intensity in the three parasitic forms after 3 h
treatment, indicating mitochondrial depolarization (Fig. 2,
Table 1). This loss of DCm was dose-dependent and signiﬁcantly
different for the three parasitic forms at all of the concentrations
tested compared with the control group. However, the loss of
DCm was noticeably more pronounced in trypomastigote and
amastigote forms, in which DCm reductions greater than 70.0%
were observed at all of the concentrations tested. Additionally, a
drop of over 90% in ﬂuorescence intensity was observed with the
higher concentration of eupomatenoid-5 (170.0 mM) for the three
parasitic forms. The positive control, CCCP, in epimastigotes,
trypomastigotes, and amastigotes induced 82.2, 84.6, and 84.7%
changes in mitochondrial membrane potential, respectively.Fig. 2. Mitochondrial membrane potential assay in parasitic forms of T. cruzi treated
mitochondria. (A) Epimastigotes treated with 23.8, 51.0, and 170.0 mM. (B) Trypomastig
and 170.0 mM. Arrows correspond to concentrations tested. Control group (untreated ce
depicted. *pr0.05, signiﬁcant difference relative to the control group (untreated cells
Table 1
Mitochondrial membrane potential assay in parasitic forms of Trypanosoma cruzi treat
Epimastigotes Trypomastigotes
mM Median IVa mM Media
Control 3078.09 0.0 Control 2942.
23.8 2072.08n 0.3 34.0 889.
51.0 1420.18n 0.5 68.0 577.
170.0 226.71n 0.9 170.0 321.
a IV¼(MTMC)/MC, where MT corresponds to the median of the ﬂuorescence for tr
n pr0.05, signiﬁcant difference relative to the control group (untreated cells).Effect of eupomatenoid-5 on cell membrane integrity of T. cruzi
Our previous work also demonstrated that eupomatenoid-5
induced cell membrane disruption [13]. This prompted us to
evaluate cell membrane integrity in eupomatenoid-5-treated
parasites. Eupomatenoid-5 affected the membrane integrity of
epimastigotes, trypomastigotes, and amastigotes of T. cruzi com-
pared with untreated cells (Fig. 3). The histograms showed an
increase in the intensity of PI ﬂuorescence (33–83% PI-positive
parasites), mainly for trypomastigotes, at all of the concentrations
tested, indicating alterations in cell membrane integrity. For
epimastigotes, at higher concentrations, approximately 60% of
the parasites were PI positive. For amastigotes, even at the higher
concentration, only 35% of the parasites were PI positive. The
positive control, digitonin, in epimastigotes, trypomastigotes, and
amastigotes increased ﬂuorescence by 99.04, 55.45, and 98.70%,
respectively.Effect of eupomatenoid-5 on mitochondrial-derived O2
d production
in T. cruzi
Changes in DCm can induce numerous mitochondrial disor-
ders that seriously compromise mitochondrial function and con-
sequently cell viability. A classic example of a disorder induced by
DCm alterations is an increase in the production of ROS through
the electron transport chain [24]. Thus, based on our DCm
results, we evaluated O2
d production in eupomatenoid-5-
treated parasites. Fig. 4 shows a signiﬁcant increase in the
production of mitochondrial O2
d at all of the concentrations
and times tested for the three parasitic forms compared with
the control group. Eupomatenoid-5 induced a pronounced effect
on trypomastigote forms, with up to threefold increases in O2
d
production after 3 h (Fig. 4B). Epimastigotes were somewhatwith eupomatenoid-5 for 3 h and stained with Rh123, which accumulates within
otes treated with 34.0, 68.0, and 170.0 mM. (C) Amastigotes treated with 34.0, 68.0,
lls) is also shown. Typical histograms of at least three independent experiments are
).
ed with eupomatenoid-5 for 3 h and stained with Rh123.
Amastigotes
n IVa mM Median IVa
73 0.0 Control 2308.24 0.0
65n 0.7 34.0 820.47n 0.7
72n 0.8 68.0 248.05n 0.9
97n 0.9 170.0 207.21n 0.9
eated parasites and MC to that for control parasites.
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d than were
amastigotes. The positive control, AA, also induced two-, three-,
and onefold increases in mitochondrial O2
d production in epi-
mastigotes, trypomastigotes, and amastigotes, respectively.
Effect of eupomatenoid-5 on oxidant species production in T. cruzi
Based on the MitoSOX data, we evaluated the effects of total
ROS/RNS production in eupomatenoid-5-treated parasites. A sig-
niﬁcant dose-dependent increase in Rh123 ﬂuorescence was
observed at all of the concentrations tested for the three parasitic
forms after 1 and 2 h treatment compared with the control group
(Fig. 5). Remarkably, with 3 h eupomatenoid-5 treatment, we
observed a signiﬁcant decrease in Rh123 ﬂuorescence at all of the
concentrations tested for the three parasitic forms compared with
1 and 2 h treatment. This signal loss at 3 h may indicate
membrane depolarization, which is consistent with our previous
DCm data. The increase in ROS/RNS production was somewhat
higher in trypomastigotes (80–150% of Rh123 ﬂuorescence) than
in epimastigotes and amastigotes (50–110% of Rh123 ﬂuores-
cence). The positive control, AA, induced an increase of 50% in
Rh123 ﬂuorescence in epimastigotes, trypomastigotes, and amas-
tigotes, even with 1 h incubation.
Effect of eupomatenoid-5 on reduced thiol levels of T. cruzi
Our data suggested that eupomatenoid-5 is an inducer of
oxidative imbalance, attributable to enhanced ROS/RNS produc-
tion. Because conditions of oxidative imbalance depend on both
increased oxidant species and decreased antioxidant effectivenessFig. 3. Cell membrane integrity assay in parasitic forms of T. cruzi treated with eupo
membrane cells. (A) Untreated epimastigotes. (B, C, D) Epimastigotes treated with 23
treated with 34.0, 68.0, and 170.0 mM. (I) Untreated amastigotes. (J, K, L) amastigotes tre
in the upper right and left quadrants. Typical histograms of at least three independent[25], our next step was to assess the activity of TR. A signiﬁcant
dose-dependent decrease in total reduced thiol levels was
observed at all of the concentrations and times tested for all three
parasitic forms compared with the control group, with the excep-
tion of epimastigotes treated with 23.8 mM eupomatenoid-5 for 3 h
(Fig. 6). Trypomastigotes were the most sensitive to the action of
eupomatenoid-5, exhibiting around 30 and 40% decreases in total
reduced thiol levels after 3 and 24 h treatment, respectively.
Effect of eupomatenoid-5 on lipid peroxidation of T. cruzi
Our previous experiment demonstrated that eupomatenoid-5
induced oxidative imbalance in T. cruzi, leading to enhanced ROS/
RNS production and impaired antioxidant defense. Based on this
we expected that eupomatenoid-5 may trigger molecular and
structural alterations in the parasite through oxidative reactions.
Strong evidence of this was provided by the plasma membrane
disruption results described above. To conﬁrm this, we measured
TBARS production, which is frequently used to quantify lipoper-
oxidation of the cell membrane, in eupomatenoid-5-treated
parasites [26]. Fig. 7 shows that the increase in MDA in the three
parasitic forms was signiﬁcantly different after 3 h compared
with the control group. This increase was dose-dependent and
more pronounced for trypomastigotes (up to 4.3-fold), followed
by epimastigotes (up to 3.3-fold) and amastigotes (up to 2.7-fold).
Effect of eupomatenoid-5 on DNA fragmentation of T. cruzi
The oxidative imbalance induced by eupomatenoid-5 might
also trigger destructive effects on DNA [27]. As shown in Fig. 8,matenoid-5 for 3 h and stained with PI, a probe that binds to DNA in ruptured
.8, 51.0, and 170.0 mM. (E) Untreated trypomastigotes. (F, G, H) Trypomastigotes
ated with 34.0, 68.0, and 170.0 mM. Percentage of PI-stained positive cells is shown
experiments are depicted.
Fig. 4. Mitochondrial O2
d production in parasitic forms of T. cruzi treated with
eupomatenoid-5 for up to 3 h using the ﬂuorescent probe MitoSOX. Parasites
preloaded with MitoSOX were incubated with various concentrations of eupomate-
noid-5. (A) Epimastigotes treated with 23.8, 51.0, and 170.0 mM. (B) Trypomastigotes
treated with 34.0, 68.0, and 170.0 mM. (C) Amastigotes treated with 34.0, 68.0, and
170.0 mM. At the indicated times parasites were used to ﬂuorimetrically measure
oxidized MitoSOX (oxMitoSOX). Results are expressed as mean ﬂuorescence (in
arbitrary units)7SD of at least three independent experiments. *pr0.05, signiﬁcant
difference relative to the control group (untreated cells).
Fig. 5. Production of ROS/RNS in parasitic forms of T. cruzi treated with eupomatenoid-
5 for up to 3 h using the nonﬂuorescent probe DHR. Parasites preloaded with DHR
were incubated with various concentrations of eupomatenoid-5 and Rh123 ﬂuores-
cence was measured. (A) Epimastigotes treated with 23.8, 51.0, and 170.0 mM.
(B) Trypomastigotes treated with 34.0, 68.0, and 170.0 mM. (C) Amastigotes treated
with 34.0, 68.0, and 170.0 mM. Results are expressed as mean ﬂuorescence (in arbitrary
units) 7 SD of at least three independent experiments. *pr0.05, treated vs control
group; #pr0.05, treated for 3 h vs treated for 1 and 2 h.
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eupomatenoid-5 and subjected to the TUNEL assay exhibited
bright ﬂuorescence, indicating DNA fragmentation compared with
untreated parasites. Additionally, counterstaining with PI in
epimastigotes, trypomastigotes, and amastigotes revealed that
eupomatenoid-5 induced chromatin condensation and margina-
tion [28]. Bright ﬂuorescence was also observed with actinomycin
D, a known inducer of apoptosis (data not shown).
Effect of eupomatenoid-5 on phosphatidylserine exposure in T. cruzi
The effect of eupomatenoid-5 on DNA prompted us to explore
the action of this compound on the apoptosis cell death pathway.
Apoptosis is characterized by several biochemical alterations,
including DNA fragmentation and phosphatidylserine exposure
[29]. Therefore, we evaluated whether eupomatenoid-5 induces
phosphatidylserine exposure. As shown in Fig. 9, the three parasiticforms treated with various concentrations of eupomatenoid-5
exhibited an increase in annexin-V ﬂuorescence intensity, indicat-
ing phosphatidylserine exposure, compared with the untreated
parasites. The histograms showed an increase of 34–56% in the
intensity of annexin-V ﬂuorescence at all of the concentrations
tested for trypomastigotes. For epimastigotes, at the higher con-
centration, annexin-V ﬂuorescence was observed in approximately
65% of the parasites. For amastigotes, even at the higher concen-
tration, annexin-V ﬂuorescence was observed in only 43% of the
parasites.
Effect of eupomatenoid-5 on cell volume of T. cruzi
In addition to biochemical alterations, apoptosis also induces
morphological alterations. Based on this, we performed additional
experiments to evaluate cell shrinkage, also a hallmark of apop-
totic death, in eupomatenoid-5-treated parasites [29]. As shown
in Fig. 10, a signiﬁcant decrease in cell volume was observed at all
of the concentrations tested for the three parasitic forms com-
pared with the control group. Additionally, trypomastigotes were
more sensitive to the effect of eupomatenoid-5, exhibiting
Fig. 6. Thiol levels in parasitic forms of T. cruzi treated with eupomatenoid-5 using
DTNB. (A) Epimastigotes treated with 23.8, 51.0, and 170.0 mM for 3, 24, and 96 h.
(B) Trypomastigotes treated with 34.0, 68.0, and 170.0 mM for 3 and 24 h.
(C) Amastigotes treated with 34.0, 68.0, and 170.0 mM for 3 and 24 h. The results
are expressed as mean7SD of at least three independent experiments. *pr0.05,
signiﬁcant difference relative to the control group (untreated cells).
Fig. 7. Lipid peroxidation in parasitic forms of T. cruzi treated with eupomatenoid-
5 for 3 h determined as the amount of TBARS in terms of MDA. (A) Epimastigotes
treated with 23.8, 51.0, and 170.0 mM. (B) Trypomastigotes treated with 34.0, 68.0,
and 170.0 mM. (C) Amastigotes treated with 34.0, 68.0, and 170.0 mM. The results
are expressed as mean7SD of at least three independent experiments. *pr0.05,
signiﬁcant difference relative to the control group (untreated cells).
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concentrations tested (Fig. 10B). The effect of eupomatenoid-5
was less in epimastigotes and amastigotes than in trypomasti-
gotes. The positive control, actinomycin D, in epimastigotes,
trypomastigotes, and amastigotes decreased cell volumes by 28,
71, and 41%, respectively.Effect of eupomatenoid-5 on the formation of autophagic vacuoles
in T. cruzi
Based on our previous transmission electron microscopy study
[12], which found abnormalities that suggested autophagosomes
on T. cruzi treated with eupomatenoid-5, we evaluated whether
autophagy is an alternative pathway of cell death induced by
eupomatenoid-5. Fig. 11 shows the presence of ﬂuorescence in
rounded structures in the three parasitic forms, indicating the
formation of autophagic vacuoles compared with untreated
parasites. This effect could be partially prevented in the parasites
pretreated with wortmannin.Discussion
Numerous natural and synthetic compounds [6,30] have been
studied over the past 100 years for the treatment of Chagas
disease since its discovery in 1909 [4]. Nevertheless, the treat-
ment of this infection remains a problem, especially in the chronic
phase of the disease when amastigotes are the predominant form.
Our previous studies demonstrated the effective and selective
action of eupomatenoid-5 against the main forms of T. cruzi.
Additionally, eupomatenoid-5 was shown to induce important
ultrastructural alterations in the three forms of T. cruzi, revealed
by electronic microscopy [12,13]. In this context, the present
study sought to further elucidate the mechanism of action of
eupomatenoid-5 in the cell death of this protozoan.
We initially focused our studies on investigating alterations in
mitochondria and the plasma membrane by staining the parasites
with Rh123 and PI. Considering the high sensitivity of these
Fig. 8. DNA fragmentation in parasitic forms of T. cruzi treated with eupomatenoid-5 for 24 h using TUNEL assay. (A–X) Differential interference contrast (DIC). (a–x)
Fluorescence images of TUNEL and PI assays. (A, a, B, b) Untreated epimastigotes. (C, c, E, e, G, g) Epimastigotes treated with 23.8, 51.0, and 170.0 mM. (D, d, F, f, H, h)
Epimastigotes treated with 23.8, 51.0, and 170.0 mM and counterstaining with PI. (I, i, J, j) Untreated trypomastigotes. (K, k, M, m, O, o) Trypomastigotes treated with 34.0,
68.0, and 170.0 mM. (L, l, N, n, P, p) Trypomastigotes treated with 34.0, 68.0, and 170.0 mM and counterstaining with PI. (Q, q, R, r) Untreated amastigotes. (S, s, U, u, X, x)
Amastigotes treated with 34.0, 68.0, and 170.0 mM. (T, t, V, v, W, w) Amastigotes treated with 34.0, 68.0, and 170.0 mM and counterstaining with PI. Green ﬂuorescence
indicates DNA fragmentation and red ﬂuorescence indicates condensation and margination of chromatin. The images are representative of treated epimastigotes,
trypomastigotes, and amastigotes of at least three independent experiments. Scale bar, 10 mm.
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Fig. 9. Phosphatidylserine exposure in parasitic forms of T. cruzi treated with eupomatenoid-5 for 3 h using annexin-V FITC and PI. (A) Untreated epimastigotes. (B, C, D)
Epimastigotes treated with 23.8, 51.0, and 170.0 mM. (E) Untreated trypomastigotes. (F, G, H) Trypomastigotes treated with 34.0, 68.0, and 170.0 mM. (I) Untreated
amastigotes. (J, K, L) Amastigotes treated with 34.0, 68.0, and 170.0 mM. Percentage of annexin-V-stained positive cells is shown in the upper and lower right quadrants.
Typical histograms of at least three independent experiments are depicted.
Fig. 10. Cell volume in parasitic forms of T. cruzi treated with eupomatenoid-5 for 3 h. (A) Epimastigotes treated with 23.8, 51.0, and 170.0 mM. (B) Trypomastigotes treated
with 34.0, 68.0, and 170.0 mM. (C) Amastigotes treated with 34.0, 68.0, and 170.0 mM. FSC-H was considered as a function of cell size. Arrows correspond to concentrations
tested. Control group (untreated cells) is also shown. Typical histograms of at least three independent experiments are depicted. *pr0.05, signiﬁcant difference relative to
the control group (untreated cells).
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the infective and nonreplicative form of T. cruzi), exhibited
marked reductions in DCm and alterations in plasma membrane
permeability. Trypomastigotes have a reduced DCm as a result of
remodeling during the life cycle of T. cruzi [31]. These data
strongly suggest that any compound (e.g., eupomatenoid-5)
with mitochondrion afﬁnity can easily reduce DCm. In fact,increasingly more papers have been published that describe
trypanocidal compounds that target T. cruzi mitochondria [24,32].
We showed that eupomatenoid-5 also induced oxidative
imbalance in the three parasitic forms, reﬂected by an increase
in ROS/RNS formation and decrease in the activity of TR, an
enzyme that participates in the hydroperoxide detoxiﬁcation of
trypanosomatids through the trypanothione-dependent system [14].
Fig. 11. Autophagic vacuoles in parasitic forms of T. cruzi treated with eupomatenoid-5 for 24 h using labeling with MDC, a ﬂuorescent probe that accumulates in
autophagic vacuoles. (A–X) DIC. (a–x) Fluorescence. (A, a, B, b) Untreated epimastigotes. (C, c, E, e, G, g) Epimastigotes treated with 23.8, 51.0, and 170.0 mM. (D, d, F, f, H, h)
Epimastigotes treated with 23.8, 51.0, and 170.0 mMþ0.5 mMwortmannin (WTM). (I, i, J, j) Untreated trypomastigotes. (K, k, M, m, O, o) Trypomastigotes treated with 34.0,
68.0, and 170.0 mM. (L, l, N, n, P, p) Trypomastigotes treated with 34.0, 68.0, and 170.0 mM þ 0.5 mM WTM. (Q, q, R, r) Untreated amastigotes. (S, s, U, u, X, x) Amastigotes
treated with 34.0, 68.0, and 170.0 mM. (T, t, V, v, W, w) Amastigotes treated with 34.0, 68.0, and 170.0 mMþ0.5 mM WTM. The images are representative of treated
epimastigotes, trypomastigotes, and amastigotes of at least three independent experiments. Scale bar, 10 mm.
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Fig. 12. Mechanistic assumptions about the trypanocidal action of eupomatenoid-
5. Eupomatenoid-5 decreases TR activity, leading to a relative increase in ROS that
triggers mitochondrial depolarization (loss of DCm) followed by an absolute
increase in mitochondrial ROS/RNS production through the electron transport
chain. This increase in ROS/RNS induces oxidative damage, leading to parasite
death.
D. Lazarin-Bido´ia et al. / Free Radical Biology and Medicine 60 (2013) 17–28 27Oxidative stress was then observed, reﬂected by lipid peroxida-
tion and DNA fragmentation. Surprisingly, these alterations were
more pronounced in trypomastigotes, which exhibit increased
levels of antioxidant enzymes and should more efﬁciently detox-
ify than the other forms [14,31]. In fact, trypanocidal compounds
have been shown to target enzymes involved in the peroxide
detoxiﬁcation of T. cruzi [33,34].
In this context, two questions arise. What came ﬁrst, the
decrease in antioxidant enzyme activity or the increase in ROS/
RNS? Should the increase in ROS/RNS formation induced by
eupomatenoid-5 be considered a cause or a consequence of
mitochondrial dysfunction? The increase in ROS/RNS formation
might occur in mitochondria. In addition to the synthesis of
adenosine triphosphate, mitochondria are also involved in the
formation of ROS/RNS [35]. Mitochondrial ROS/RNS formation is
essential in many signaling processes and strongly involved in the
degenerative process through damage to macromolecules, mainly
proteins, lipids, and DNA [31,36–38]. However, the increase in
ROS/RNS might also involve antioxidant enzyme impairment. Our
thiol, DHR, MitoSOX, and Rh123 data give us support to answer
these questions. Eupomatenoid-5 decreased TR activity and
increased ROS/RNS formation as soon as treatment began.
In contrast, eupomatenoid-5 induced mitochondrial membrane
depolarization only after 3 h treatment, which was observed in
the Rh123 and DHR assays. Our overall hypothesis is that the
mechanism of action of eupomatenoid-5 involves a decrease in
hydroperoxide detoxiﬁcation by reducing TR activity, leading to a
relative increase in ROS that triggers mitochondrial depolariza-
tion, followed by an absolute increase in mitochondrial ROS/RNS
production through the electron transport chain (Fig. 12). This
increase in ROS/RNS then acts in any membrane of the parasite,
including the mitochondrial membrane, further impairing mito-
chondrial function and possibly inducing more ROS/RNS genera-
tion [39,40]. This scenario made us believe that the increase in
ROS/RNS is both a cause and a consequence of mitochondrial
dysfunction. This phenomenon is conceivable and well supported
by the ROS-induced ROS-release process [41].
The experiments presented herein provide evidence that
eupomatenoid-5 induced biochemical andmorphological alterations
in T. cruzi, leading to parasite death. Based on the present DNA
fragmentation, phosphatidylserine exposure, and reduced parasite
volume data, we strongly believe that apoptosis is a cell death
pathway involved in the trypanocidal action of eupomatenoid-5.
Based on plasma membrane disruption, necrosis could also be an
alternative pathway of cell death induced by eupomatenoid-5.In addition to apoptosis and necrosis, the presence of autophagic
vacuoles, revealed by MDC labeling, suggests autophagic death. All
of these cell death pathways have been well described for trypano-
somatids, with signiﬁcant mitochondrion participation [20,42,43].
Classic ways in which these parasite mitochondria are involved in
apoptosis, necrosis, and autophagy include a loss of membrane
potential and increase in ROS formation [29,44,45]. Accumulating
evidence suggests that a key event in the transition from apoptosis
to necrosis or autophagy involves an excessive increase in mito-
chondrial ROS formation [40,44].
In conclusion, the present data provide further insights into
the mechanisms of action of eupomatenoid-5. Additionally, our
data strongly suggest that eupomatenoid-5 is an effective com-
pound to treat Chagas disease, with remarkable trypanocidal
action against the three main forms of T. cruzi, including trypo-
mastigotes and amastigotes. Therefore, eupomatenoid-5 might be
an effective compound for further in vivo analysis. Notably, our
data indicate that the trypomastigote form is the most sensitive
to the effects of eupomatenoid-5. Trypomastigotes are the only
nonreplicative form of the T. cruzi life cycle. Metacyclogenesis, the
process by which the various forms of T. cruzi are transformed
from noninfectious and replicative into infectious and nonproli-
ferative, remains unclear. The literature provides information
only about changes in the pattern of gene expression [46,47].
Therefore, our hypothesis is that eupomatenoid-5 might take
advantage of this process and have more efﬁcient actions against
trypomastigote forms of T. cruzi. Actually, drug resistance is well
known for the various strains of T. cruzi because this parasite is a
heterogeneous group with morphological, physiological, bio-
chemical, and clinical diversity [48].Acknowledgments
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